Abstract
Presently, there is no practical laboratory animal model for the evaluation of experimental gonococcal vaccines. The chimpanzee has been used recently (1), but this animal is expensive and difficult to handle. On the other hand, the. susceptibility of the chick embryo to certain pathogenic microorganisms has provided an excellent model for the study of their virulence (2,3,8,9). In our laboratory, we have confirmed the original observation of Bumgarner et al (4), that Neisseria gonorrhoeae colony types T1 and T2 (virulent for man) are significantly more virulent for the chick embryo than T3 and T4 (non-virulent for man). However, chick embryo neutralization studies (4,5) have shown the unsuitability of the embryo as an animal model for the protective capacity of vaccines against gonorrhea, since there is only a ten-fold difference between the ability of normal and hyper-immune rabbit sera to protect the embryos against gonococcal challenge. Because of these limitations, we have investigated the ability of embryos obtained from Leghorn hens immunized intravenously with experimental gonococcal vaccines, to withstand a challenge with N. gonorrhoeae